These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 39052867)
1. Integrative Omics Uncovers Low Tumorous Magnesium Content as A Driver Factor of Colorectal Cancer. Zhang R; Hu M; Liu Y; Li W; Xu Z; He S; Lu Y; Gong Y; Wang X; Hai S; Li S; Qi S; Li Y; Shu Y; Du D; Zhang H; Xu H; Zhou Z; Lei P; Chen HN; Dai L Genomics Proteomics Bioinformatics; 2024 Oct; 22(4):. PubMed ID: 39052867 [TBL] [Abstract][Full Text] [Related]
2. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1. Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364 [TBL] [Abstract][Full Text] [Related]
3. Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. Han X; Fang X; Lou X; Hua D; Ding W; Foltz G; Hood L; Yuan Y; Lin B PLoS One; 2012; 7(8):e41335. PubMed ID: 22912670 [TBL] [Abstract][Full Text] [Related]
4. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation. Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839 [TBL] [Abstract][Full Text] [Related]
5. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype. Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541 [TBL] [Abstract][Full Text] [Related]
6. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells. Li H; Rokavec M; Jiang L; Horst D; Hermeking H Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028 [TBL] [Abstract][Full Text] [Related]
7. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity. Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833 [TBL] [Abstract][Full Text] [Related]
8. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer. An HT; Yoo S; Ko J Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319 [TBL] [Abstract][Full Text] [Related]
9. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer. Lu K; Dong JL; Fan WJ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860 [TBL] [Abstract][Full Text] [Related]
10. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition. Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728 [TBL] [Abstract][Full Text] [Related]
11. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression. Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914 [TBL] [Abstract][Full Text] [Related]
12. Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer. Zhang H; Yang W; Yan J; Zhou K; Wan B; Shi P; Chen Y; He S; Li D Int J Oncol; 2018 Sep; 53(3):1118-1128. PubMed ID: 30015842 [TBL] [Abstract][Full Text] [Related]
13. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice. Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235 [TBL] [Abstract][Full Text] [Related]
14. Pseudopod-associated protein KIF20B promotes Gli1-induced epithelial-mesenchymal transition modulated by pseudopodial actin dynamic in human colorectal cancer. Lin WF; Lin XL; Fu SW; Yang L; Tang CT; Gao YJ; Chen HY; Ge ZZ Mol Carcinog; 2018 Jul; 57(7):911-925. PubMed ID: 29573464 [TBL] [Abstract][Full Text] [Related]
15. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer. Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571 [TBL] [Abstract][Full Text] [Related]
17. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition. Yang Z; Wu D; Chen Y; Min Z; Quan Y Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022 [TBL] [Abstract][Full Text] [Related]
18. Integrated Multi-Omics Investigations of Metalloproteinases in Colon Cancer: Focus on MMP2 and MMP9. Buttacavoli M; Di Cara G; Roz E; Pucci-Minafra I; Feo S; Cancemi P Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830271 [TBL] [Abstract][Full Text] [Related]
19. DJ-1 promotes epithelial-to-mesenchymal transition via enhancing FGF9 expression in colorectal cancer. Li L; Zhang C; Li Y; Zhang Y; Lei Y Biol Open; 2020 May; 9(5):. PubMed ID: 32366371 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]